Drugs / Seresis®
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02191852 | Jun → Oct 1999 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02191787 | Mar → May 1998 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02191813 | Mar → Jul 2000 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Seresis | “Study to Determine the Ability of Seresis to Act as a Skin Protection Agent in Healthy Young Female Volunteers” NCT02191813 ↗ |